FunPep Company Limited

4881

JP3802640007

Biotechnology & Medical Research

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-26 am EDT			5-day change	1st Jan Change
146 ^JPY	-1.35%		-3.31%	+8.15%

Mar. 21	FunPep Company Limited announced that it has received ¥199.9998 million in funding from Shionogi & Co., Ltd.	CI
Mar. 04	FunPep Company Limited announced that it expects to receive ¥199.9998 million in funding from Shionogi & Co., Ltd.	CI

FunPep Company Limited has filed an IPO.

November 20, 2020 at 12:00 am EST

FunPep Company Limited has filed an IPO. Security Name: Shares Security Type: Common Stock Securities Offered: 2,739,700

Latest news about FunPep Company Limited

FunPep Company Limited announced that it has received ¥199.9998 million in funding from Shionogi & Co., Ltd.	Mar. 20	CI
FunPep Company Limited announced that it expects to receive ¥199.9998 million in funding from Shionogi & Co., Ltd.	Mar. 03	CI
FunPep Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023	Nov. 14	CI
FunPep Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
FunPep Company Limited completed the acquisition of Anti-Aging Peptide Co., Ltd. from Hironori Nakagami , Bio Site Start Fund L.P., Naotaka Hashiya, Chiyako Ueda, ReBeage Co., Ltd. and others.	22-09-30	CI
FunPep Company Limited agreed to acquire Anti-Aging Peptide Co., Ltd. from Hironori Nakagami , Bio Site Start Fund L.P., Naotaka Hashiya, Chiyako Ueda, ReBeage Co., Ltd. and others.	22-07-13	CI
FunPep Company Limited announced that it has received ¥3.741 million in funding from SBI Securities Co., Ltd., Investment Arm	21-12-12	CI
FunPep Company Limited announced that it expects to receive ?3.741 million in funding from SBI Securities Co., Ltd., Investment Arm	21-11-25	CI
FunPep Company Limited has completed an IPO in the amount of ¥1.780805 billion.	20-12-25	CI
FunPep Company Limited has filed an IPO.	20-11-20	CI
FunPep Company Limited has withdrawn its IPO.	20-11-14	CI
FunPep Company Limited has filed an IPO.	19-11-18	CI
FunPep Co., Ltd. announced that it has received ¥460 million in funding from a group of investors	18-10-04	CI
FunPep Co., Ltd. announced that it has received ¥100 million in funding from OSAKA University Venture Capital Co., Ltd.	16-04-13	CI
Funpep Co., Ltd. announced that it has received funding from Japan Science And Technology Agency and other investors.	15-11-29	CI

FunPep Co Ltd is a Japan-based company engaged in the research and development business for pharmaceuticals. The main business is to promote research and development of functional peptides, which are the results of research at the Graduate School of Medicine, Osaka University, and to put them into practical use in the business fields such as pharmaceuticals, cosmetics and medical devices. The business model defines its technical area as a functional peptide-based area and a related area that has synergies with it. The Research & Development pipeline is composed of research themes for antibody-inducing peptides and developed products. The Company is engaged in the sale of peptide active ingredients through cosmetic raw material trading companies or sales companies.

Sector

Biotechnology & Medical Research

Calendar

2024-05-12 - Q1 2024 Earnings Release

More about the company

	1st Jan change	Capi.
FUNPEP COMPANY LIMITED	+8.15%	24.75M
IQVIA HOLDINGS INC.	+1.92%	42.59B
MODERNA, INC.	+7.84%	40.65B
LONZA GROUP AG	+49.22%	40.57B
CELLTRION, INC.	-11.96%	26.77B
ICON PUBLIC LIMITED COMPANY	+9.48%	24.81B
ALNYLAM PHARMACEUTICALS, INC.	-24.28%	18.17B
MEDPACE HOLDINGS, INC.	+27.24%	12.05B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.47%	11.7B
UNITED THERAPEUTICS CORPORATION	+6.92%	11.1B

Other Biotechnology & Medical Research